Literature DB >> 19353991

A comparison of reasons for choosing obstetrician/gynecologist subspecialty training.

Yu Ming Victor Fang1, James F X Egan, Tali Rombro, Bruce Morris, Carolyn M Zelop.   

Abstract

Recently, applications for subspecialty fellowship positions in obstetrics and gynecology have increased dramatically. A survey completed by fellows in Maternal-Fetal Medicine (MFM), Reproductive Endocrinology (REI), Gynecologic Oncology (Gyn Onc), and Urogynecology (Urogyn) training programs in the United States between January and March 2006 was aimed at determining why this trend was occuring. Of 449 fellows in 2006, 192 (42.8%) responded. The two most influential factors in all four subspecialties were interest and lifestyle (P < .001). Although these factors were similar throughout all subspecialties, variations exist in how fellows rated each factor by subspecialty. An overwhelming majority (99%) of fellows were either "very satisfied" or "satisfied" with their decisions to pursue fellowship training. The majority of fellows believe that when compared to a generalist Obstetrician/Gynecologist (OB/GYN) they will have a reduced workload, decreased liability, and a higher salary. The recent increase in the number of fellowship applicants is most likely due to a complex interplay of multiple factors.

Entities:  

Mesh:

Year:  2009        PMID: 19353991

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  2 in total

1.  Unverifiable accomplishments and publications on applications for gynecologic oncology fellowships.

Authors:  Michael Frumovitz; Maya L Kriseman; Charlotte C Sun; Jennifer Blumenthal-Barby; Anil K Sood; Diane C Bodurka; Pamela T Soliman
Journal:  Obstet Gynecol       Date:  2012-03       Impact factor: 7.661

2.  Factors influencing residents' interest in gynecologic oncology fellowship.

Authors:  Marguerite Palisoul; Molly Greenwade; Leslie S Massad; Andrea Hagemann; Matthew Powell; David Mutch; Candice Woolfolk; Lindsay Kuroki
Journal:  Gynecol Oncol Rep       Date:  2019-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.